Tech Policy
CDC weighs $1.6M for newborn hepatitis B trial amid ethics outcry
The CDC kept $1.6 million aside for a Guinea-Bissau study that would withhold a birth vaccine from half the babies. Then the country said no.
The CDC kept $1.6 million aside for a Guinea-Bissau study that would withhold a birth vaccine from half the babies. Then the country said no.
The Daily Brief
Every morning, the news that matters from AI, phones, apps and the people shaping tech. Explained in plain English. Free.
One email a day. No spam, unsubscribe anytime. Privacy policy